Patents by Inventor Philippe Goffin

Philippe Goffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10696997
    Abstract: A cassette sequence for the transformation of a host cell includes at least: a first nucleotide sequence encoding a peptide or protein of interest to be produced by the host cell. The first sequence is linked to a second nucleotide sequence providing resistance to a toxin or encoding an antitoxin peptide to the toxin. The nucleotide sequences are organized in such a way that production of the peptide encoded by the second nucleotide sequence(s) is translationally coupled to production of the peptide encoded by the first nucleotide sequence.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: June 30, 2020
    Assignee: UNIVERSITE LIBRE DE BRUXELLES
    Inventors: Laurence Van Melderen, Baptiste J. S. Dumont, Thibaut Hallaert, Gilles Vanwalleghem, Philippe Goffin
  • Publication number: 20190322708
    Abstract: Methods for the production of a bacterial toxin such as diphtheria toxin, and methods for producing conjugates of a bacterial toxins, are provided.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 24, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin
  • Publication number: 20180258146
    Abstract: Methods for producing a conjugate of a bacterial toxin, including diphtheria toxin or CRM197, are provided.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 13, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Normand BLAIS, Philippe Marc Helene DEHOTTAY, Marianne DEWERCHIN, Philippe GOFFIN, Denis MARTIN
  • Patent number: 9994622
    Abstract: Compositions and methods related to periplasmic expression of a toxin including diphtheria toxin or CRM197 are provided herein.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: June 12, 2018
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin
  • Publication number: 20170314053
    Abstract: A cassette sequence for the transformation of a host cell includes at least: a first nucleotide sequence encoding a peptide or protein of interest to be produced by the host cell. The first sequence is linked to a second nucleotide sequence providing resistance to a toxin or encoding an antitoxin peptide to the toxin. The nucleotide sequences are organized in such a way that production of the peptide encoded by the second nucleotide sequence(s) is translationally coupled to production of the peptide encoded by the first nucleotide sequence.
    Type: Application
    Filed: July 6, 2015
    Publication date: November 2, 2017
    Applicant: UNIVERSITE LIBRE DE BRUXELLES
    Inventors: Laurence VAN MELDEREN, Baptiste J. S. DUMONT, Thibaut HALLAERT, Gilles VANWALLEGHEM, Philippe GOFFIN
  • Patent number: 9765294
    Abstract: Chemically defined media for the industrial-scale culture of Bordetella species.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: September 19, 2017
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Marc Helene Dehottay, Philippe Goffin, Filipe Branco dos Santos, Bas Teusink
  • Publication number: 20170137475
    Abstract: Compositions and methods related to periplasmic expression of a toxin including diphtheria toxin or CRM197 are provided herein.
    Type: Application
    Filed: July 14, 2016
    Publication date: May 18, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Normand BLAIS, Philippe Marc Helene DEHOTTAY, Marianne DEWERCHIN, Philippe GOFFIN, Denis MARTIN
  • Publication number: 20160378909
    Abstract: Methods for identifying culture conditions for a cell, the method comprising: (a) obtaining a genome scale stoichiometric metabolic model of the cell, and (b) performing constraint based optimization on the metabolic model of the cell using at least one yield based constraint.
    Type: Application
    Filed: December 15, 2014
    Publication date: December 29, 2016
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Philippe Marc Helene DEHOTTAY, Philippe GOFFIN, Bas TEUSINK, Filipe BRANCO DOS SANTOS
  • Patent number: 9475848
    Abstract: A process for fermenting Bordetella species comprising incubating a sample of bacteria of a Bordetella species in a first environment under at least one bvg (Bordetella virulence genes) modulating condition, for at least 5 generations, to produce a mature culture, and then incubating the mature culture in a second environment in the absence of the at least one bvg modulating condition.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: October 25, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Marc Helene Dehottay, Philippe Goffin
  • Patent number: 9422345
    Abstract: Polynucleotides are provided herein.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: August 23, 2016
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin
  • Publication number: 20160222344
    Abstract: Chemically defined media for the industrial-scale culture of Bordetella species.
    Type: Application
    Filed: September 11, 2014
    Publication date: August 4, 2016
    Inventors: Philippe Marc Helene DEHOTTAY, Philippe GOFFIN, Filipe Branco dos Santos, Bas TEUSINK
  • Patent number: 9346861
    Abstract: The present invention provides a process for periplasmic expression of a bacterial toxoid comprising the steps of: a) growing a culture of a gram negative host cell in a fermentation medium, wherein the host cell is transformed with a polynucleotide, and wherein the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence; or providing a gram negative host cell wherein the host cell is transformed with a polynucleotide, the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence and wherein the gram negative host cell comprises the bacterial toxoid expressed in the periplasm; a(i)) inducing expression of the bacterial toxoid; b) maturing the host cell, wherein the maturing step comprises: I) subjecting the host cell to a pH shock; II) incubating the host cell with no feed addition; and/or III) subjecting the host cell to a temperature below ?20° C.; and c) extracting the bacterial toxoid from the host cell wherein the extraction process comprises osmotic shock.
    Type: Grant
    Filed: April 12, 2012
    Date of Patent: May 24, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Marc Helene Dehottay, Philippe Goffin
  • Publication number: 20150010948
    Abstract: A process for fermenting Bordetella species comprising incubating a sample of bacteria of a Bordetella species in a first environment under at least one bvg (Bordetella virulence genes) modulating condition, for at least 5 generations, to produce a mature culture, and then incubating the mature culture in a second environment in the absence of the at least one bvg modulating condition.
    Type: Application
    Filed: January 30, 2013
    Publication date: January 8, 2015
    Inventors: Philippe Marc Helene Dehottay, Philippe Goffin
  • Publication number: 20140050758
    Abstract: The present invention provides a process for periplasmic expression of a bacterial toxoid comprising the steps of: a), growing a culture of a gram negative host cell in a fermentation medium, wherein the host cell is transformed with a polynucleotide, and wherein the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence; or providing a gram negative host cell wherein the host cell is transformed with a polynucleotide, the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence and wherein the gram negative host cell comprises the bacterial toxoid expressed in the periplasm; a(i)) inducing expression of the bacterial toxoid; b) maturing the host ceil, wherein the maturing step comprises; I) subjecting the host cell to a pH shock; II) incubating the host ceil with no feed addition; and/or III) subjecting the host ceil to a temperature below ?20° C.; and c) extracting the bacterial toxoid from the host cell wherein the extraction process comprises osmotic shock.
    Type: Application
    Filed: April 12, 2012
    Publication date: February 20, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Philippe Marc Helene Dohottay, Philippe Goffin
  • Publication number: 20120289688
    Abstract: Polynucleotides are provided herein.
    Type: Application
    Filed: October 7, 2010
    Publication date: November 15, 2012
    Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin